DLB vs. QGEN

In the year-to-date period, DLB achieves a -6.82% return, which is significantly higher than QGEN's -14.14% return. Over the past 10 years, DLB has outperformed QGEN with an annualized return of 7.99%, while QGEN has yielded a comparatively lower 4.18% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DLB Sharpe Ratio is -0.41, which is comparable to the QGEN Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of DLB and QGEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

DLB's dividend yield for the trailing twelve months is around 1.74%, less than QGEN's 3.29% yield.

The maximum DLB drawdown since its inception was -62.19%, smaller than the maximum QGEN drawdown of -92.14%. Use the drawdown chart below to compare losses from any high point for DLB and QGEN. For additional features, visit the drawdowns tool.

Dolby Laboratories, Inc. (DLB) has a higher volatility of 9.22% compared to Qiagen N.V. (QGEN) at 6.94%. This indicates that DLB's price experiences larger fluctuations and is considered to be riskier than QGEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Dolby Laboratories, Inc. and Qiagen N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.